Ibuprofen is used daily by millions, but new research is examining whether the painkiller may also be associated with changes in cancer risk.
Focus on ibuprofen has increased following results from a large study known as PLCO. More than 42,000 women were followed for over 12 years.
According to the researchers behind the study, women who used ibuprofen regularly had a lower risk of developing uterine cancer than women who rarely used the drug.
The finding has attracted attention because ibuprofen is easily accessible and widely used in everyday life.
Also read: Study links shingles vaccination to slower biological aging
Science Daily reports that the effect was particularly observed in older women with heart disease.
Why researchers are taking a closer look at ibuprofen
The interest is linked to new knowledge about inflammation. Inflammatory conditions in the body play a role in the development of several types of cancer.
Ibuprofen works by reducing inflammation, and according to The Conversation, researchers have therefore examined whether the drug may also influence cancer risk.
At a time when populations are ageing and the use of painkillers is widespread, it is relevant to understand both the beneficial and harmful long-term effects.
Also read: New research explains why lack of sleep weakens your concentration
Uncertainty and clear warnings
Although the results have sparked interest, the picture is not clear-cut. The studies show associations but do not prove that ibuprofen directly prevents cancer.
Other studies have even pointed to an increased risk associated with the use of similar medications after a cancer diagnosis.
At the same time, long-term use can cause serious side effects such as gastrointestinal bleeding and kidney damage.
Experts therefore stress, according to Science Daily, that ibuprofen should not be used as a preventive measure.
Also read: These beverages may be problematic for your blood pressure
Sources: Science Daily, PLCO, and The Conversation.
Also read: Why carbonated drinks appeal more to some people than others
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.